These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6727551)

  • 41. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
    Barrett AC; Smith ES; Picker MJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spinal fluid kinetics of morphine and heroin.
    Moore A; Bullingham R; McQuay H; Allen M; Baldwin D; Cole A
    Clin Pharmacol Ther; 1984 Jan; 35(1):40-5. PubMed ID: 6546305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
    Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
    Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opioid interactions with alcohol.
    Kreek MJ
    Adv Alcohol Subst Abuse; 1984; 3(4):35-46. PubMed ID: 6391108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different effects of di-isopropylfluorophosphate on the entry of opioids into mouse brain.
    Green PG; Kitchen I
    Br J Pharmacol; 1985 Mar; 84(3):657-61. PubMed ID: 2859063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic extraction of morphine is impaired in cirrhosis.
    Crotty B; Watson KJ; Desmond PV; Mashford ML; Wood LJ; Colman J; Dudley FJ
    Eur J Clin Pharmacol; 1989; 36(5):501-6. PubMed ID: 2753069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different patterns of administration modulate propensity of methadone and buprenorphine to promote locomotor sensitization in mice.
    Allouche S; Le Marec T; Noble F; Marie N
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():286-91. PubMed ID: 23103550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphine glucuronidation in the rhesus monkey: a comparative in vivo and in vitro study.
    Rane A; Säwe J; Lindberg B; Svensson JO; Garle M; Erwald R; Jorulf H
    J Pharmacol Exp Ther; 1984 May; 229(2):571-6. PubMed ID: 6716277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal diamorphine as an alternative to intramuscular morphine: pharmacokinetic and pharmacodynamic aspects.
    Kendall JM; Latter VS
    Clin Pharmacokinet; 2003; 42(6):501-13. PubMed ID: 12793836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The mu, delta and kappa properties of various opioids].
    Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S
    Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
    Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
    Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics of heroin and its major metabolites.
    Rook EJ; Huitema AD; van den Brink W; van Ree JM; Beijnen JH
    Clin Pharmacokinet; 2006; 45(4):401-17. PubMed ID: 16584286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Feb; 17(2):81-110. PubMed ID: 378645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses.
    Martucci C; Panerai AE; Sacerdote P
    Pain; 2004 Jul; 110(1-2):385-92. PubMed ID: 15275790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain.
    Wolff RF; Aune D; Truyers C; Hernandez AV; Misso K; Riemsma R; Kleijnen J
    Curr Med Res Opin; 2012 May; 28(5):833-45. PubMed ID: 22443154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.
    Moody DE
    Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):675-97. PubMed ID: 23537174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method.
    Azar P; Nikoo M; Miles I
    Am J Addict; 2018 Dec; 27(8):601-604. PubMed ID: 30387894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine.
    Kristensen K; Christensen CB; Christrup LL
    Life Sci; 1995; 56(2):PL45-50. PubMed ID: 7823756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.